UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature (London), ISSN 0028-0836, 10/2019, Volume 574, Issue 7776, pp. 45 - 56
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Care and treatment | Forecasts and trends | Immunotherapy | Cancer | DNA damage | Antibodies | Cytotoxicity | Innate immunity | Lymphocytes T | Genomes | Metastasis | Cancer therapies | Immunity | Pathways | Lymphocytes | Tumor necrosis factor-TNF | Deoxyribonucleic acid--DNA | Antigens | Immunoglobulins | Dendritic cells | Immunomodulation | Melanoma | Chimeric antigen receptors | Immune checkpoint | Ligands | Bispecific antibodies | Tumors | Apoptosis | Index Medicus
Journal Article
Cell reports (Cambridge), ISSN 2211-1247, 05/2019, Volume 27, Issue 8, pp. 2411 - 2425.e9
Journal Article
Nature (London), ISSN 0028-0836, 12/2020, Volume 588, Issue 7836, pp. 146 - 150
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | COVID-19 - immunology | Inflammation - pathology | Humans | Bronchoalveolar Lavage Fluid - immunology | Respiratory Distress Syndrome - immunology | Complement C5a - biosynthesis | Inflammation - complications | Respiratory Distress Syndrome - prevention & control | Acute Lung Injury - prevention & control | COVID-19 - complications | Inflammation - drug therapy | Myeloid Cells - immunology | COVID-19 - blood | Receptor, Anaphylatoxin C5a - immunology | SARS-CoV-2 - drug effects | Female | Myeloid Cells - drug effects | Respiratory Distress Syndrome - drug therapy | SARS-CoV-2 - immunology | Acute Lung Injury - drug therapy | Cytokine Release Syndrome - drug therapy | Disease Models, Animal | Cytokine Release Syndrome - immunology | Lung - pathology | CD11b Antigen - immunology | Cytokine Release Syndrome - prevention & control | Mice, Inbred C57BL | Inflammation - immunology | Complement C5a - antagonists & inhibitors | Animals | SARS-CoV-2 - pathogenicity | Receptor, Anaphylatoxin C5a - blood | Lung - drug effects | COVID-19 - pathology | Acute Lung Injury - immunology | Mice | Bronchoalveolar Lavage Fluid - chemistry | CD11b Antigen - metabolism | Complement C5a - immunology | Myeloid Cells - pathology | Receptor, Anaphylatoxin C5a - antagonists & inhibitors | Lung - immunology | Myeloid cells | Immune response | Complement component C5a | Severe acute respiratory syndrome | Viral diseases | Organs | Bronchus | Leukocytes (neutrophilic) | Inflammation | Coronaviruses | Blood | Recruitment | Severe acute respiratory syndrome coronavirus 2 | COVID-19 | Smoke inhalation | Receptors | Cell activation | Respiratory distress syndrome | Lungs | Bronchoalveolar lavage | Respiratory diseases | Monoclonal antibodies | Alveoli | Immune system | Index Medicus
Journal Article
Cell (Cambridge), ISSN 0092-8674, 12/2018, Volume 175, Issue 7, pp. 1731 - 1743.e13
natural killer cells | CD8+ T cells | lymphocytes | cancer immunotherapy | inhibitory receptors | therapeutic monoclonal antibodies | immunce checkpoint inhibitor | CD8 | T cells | CD8(+) T cells | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | CD8-Positive T-Lymphocytes - pathology | NK Cell Lectin-Like Receptor Subfamily C - antagonists & inhibitors | Carcinoma, Squamous Cell - pathology | Humans | Carcinoma, Squamous Cell - therapy | Killer Cells, Natural - pathology | Cetuximab - therapeutic use | Carcinoma, Squamous Cell - immunology | NK Cell Lectin-Like Receptor Subfamily C - immunology | Animals | Immunity, Cellular - drug effects | Antineoplastic Agents, Immunological - therapeutic use | Immunotherapy | Killer Cells, Natural - immunology | Mice | CD8-Positive T-Lymphocytes - immunology | Clinical Trials, Phase II as Topic | Prevention | Fc receptors | Squamous cell carcinoma | Killer cells | Resveratrol | Monoclonal antibodies | Cancer | Index Medicus | Life Sciences | Immunology
Journal Article
Nature (London), ISSN 0028-0836, 12/2019, Volume 576, Issue 7785, pp. E3 - E3
Journal Article
Cell (Cambridge), ISSN 0092-8674, 06/2019, Volume 177, Issue 7, pp. 1701 - 1713.e16
natural killer cells | cancer immunotherapy | monoclonal antibodies | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Humans | Neoplasms, Experimental - therapy | Killer Cells, Natural - pathology | Antibodies, Bispecific - immunology | Antineoplastic Agents, Immunological - pharmacology | Neoplasms, Experimental - pathology | Antibodies, Bispecific - therapeutic use | Animals | Antigens, Ly - immunology | Antineoplastic Agents, Immunological - immunology | Immunoglobulin G - immunology | Neoplasms, Experimental - immunology | Immunoglobulin G - pharmacology | Killer Cells, Natural - immunology | Mice | Natural Cytotoxicity Triggering Receptor 1 - immunology | Cytotoxicity, Immunologic - drug effects | Viral antibodies | Killer cells | Analysis | Immunotherapy | Tumor antigens | Antibodies | T cells | Cancer | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 03/2010, Volume 115, Issue 10, pp. 1949 - 1957
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Biological and medical sciences | Medical sciences | Adjuvants, Immunologic - pharmacology | Imiquimod | Cancer Vaccines - pharmacology | Dendritic Cells - immunology | Melanoma, Experimental - metabolism | Quinolines - pharmacology | Dose-Response Relationship, Drug | Melanoma, Experimental - immunology | Interferon Type I - metabolism | Antineoplastic Agents - pharmacology | Interferon Type I - physiology | Receptor, Interferon alpha-beta - genetics | Imidazoles - therapeutic use | Tumor Cells, Cultured | Aminoquinolines - pharmacology | Dendritic Cells - metabolism | Toll-Like Receptor 7 - agonists | Melanoma, Experimental - therapy | Mice, Inbred C57BL | Membrane Glycoproteins - agonists | Imidazoles - pharmacology | Mice, Knockout | Animals | RNA - pharmacology | Mice | Aminoquinolines - therapeutic use | Index Medicus | Abridged Index Medicus | Immunobiology
Journal Article
Cellular & molecular immunology, ISSN 1672-7681, 09/2020, Volume 17, Issue 9, pp. 995 - 997
Life Sciences & Biomedicine | Immunology | Science & Technology | Betacoronavirus - pathogenicity | T-Lymphocyte Subsets - immunology | NK Cell Lectin-Like Receptor Subfamily C - antagonists & inhibitors | Pandemics | Gene Expression - drug effects | Severe Acute Respiratory Syndrome - virology | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | NK Cell Lectin-Like Receptor Subfamily C - genetics | Severe Acute Respiratory Syndrome - immunology | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Killer Cells, Natural - pathology | Case-Control Studies | Betacoronavirus - immunology | COVID-19 | NK Cell Lectin-Like Receptor Subfamily C - immunology | SARS-CoV-2 | Pneumonia, Viral - genetics | Killer Cells, Natural - immunology | Pneumonia - immunology | B-Lymphocytes - pathology | Molecular Targeted Therapy - methods | Pneumonia - genetics | Apyrase - antagonists & inhibitors | Antiviral Agents - therapeutic use | Apyrase - immunology | Coronavirus Infections - genetics | Severe Acute Respiratory Syndrome - drug therapy | B7-H1 Antigen - genetics | B7-H1 Antigen - immunology | Coronavirus Infections - immunology | Pneumonia - virology |